Literature DB >> 18485151

Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations.

Aurélie Bocquier1, Kamel Bezzou, Steve Nauleau, Pierre Verger.   

Abstract

We examined geographic variations in the dispensing of anxiolytics and hypnotics (AX-HY) and their determinants at the canton level in southeastern France. Data were collected from the 2005 outpatient database of the Southeastern France General Health Insurance Fund, covering more than 70% of the population. We calculated the annual age-adjusted prevalence rates of subjects filling prescriptions for AX-HY at least once (to measure 'overall use') and at least six times ('chronic use'), assessed geographic variations with the extremal quotient and weighted coefficient of variation, and conducted simple and multiple linear regression analysis to study their determinants. Prevalence rates of overall and chronic AX-HY use were 15.5% and 5.9%, respectively, and varied significantly between cantons, by a factor of 3-4. The prevalence of mental illness and that of chronic illness were independently and positively associated with overall and chronic use; unemployment rates and mean family income were positively associated only with overall use. Density of general practitioners did not explain geographic variations. These results provide a basis for targeting interventions to reduce AX-HY use and promoting appropriate discontinuation. Future studies should examine trends in those geographic variations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485151     DOI: 10.1111/j.1472-8206.2008.00587.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  4 in total

1.  Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system.

Authors:  B Bongue; M L Laroche; S Gutton; A Colvez; R Guéguen; J J Moulin; L Merle
Journal:  Eur J Clin Pharmacol       Date:  2011-06-21       Impact factor: 2.953

Review 2.  Polypharmacy for schizophrenia.

Authors:  Jacob Ballon; T Scott Stroup
Journal:  Curr Opin Psychiatry       Date:  2013-03       Impact factor: 4.741

3.  General practitioners and patients with psychological stress at work.

Authors:  M Souville; S Cabut; A Viau; G Iarmarcovai; S Arnaud; P Verger
Journal:  J Occup Rehabil       Date:  2009-05-22

4.  Psychotropic Drug Consumption Among Older People Enrolled in a French Private Health Insurance Plan.

Authors:  Oren Semoun; Christine Sevilla-Dedieu
Journal:  Drugs Real World Outcomes       Date:  2015-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.